| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 14,176 | 15,424 | 8,640 | 12,244 | | Cost of Revenue | 7,896 | 11,111 | 7,433 | 7,617 | | | Gross Profit | 6,280 | 4,313 | 1,207 | 4,627 | | | Operating Expenses | | Research Development | 2,575 | 3,075 | 4,631 | 4,393 | | Selling General and Administrative | 3,869 | 3,907 | 6,071 | 5,657 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (164) | (2,669) | (9,495) | (5,423) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (87) | (61) | 120 | 112 | | Earnings Before Interest And Taxes | (251) | (2,730) | (9,375) | (5,311) | | Interest Expense | 3 | 8 | 13 | 17 | | Income Before Tax | (254) | (2,738) | (9,388) | (5,328) | | Income Tax Expense | (182) | 70 | 39 | (11) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (72) | (2,808) | (9,427) | (5,317) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (72) | (2,808) | (9,427) | (5,317) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($72) | ($2,808) | ($9,427) | ($5,317) |
|
0.04% Nasdaq 
0.25%
Income Statement
